SOLIGENIX, INC. Common Stock, Value, Issued
SOLIGENIX, INC. (SNGX) had Common Stock, Value, Issued of $21.64 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-07
- 2026-06-30: Common Stock, Value, Issued $21.64K.
- 2026-03-31: Common Stock, Value, Issued $10.52K.
- 2025-12-31: Common Stock, Value, Issued $10.09K.
- 2025-09-30: Common Stock, Value, Issued $9.86K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $21.64K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $10.52K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $10.09K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $9.86K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $3.50K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.18K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $2.51K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.29K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.54K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $10.52K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $649.00 10-K · filed 2025-03-21 | $10.38K 10-K · filed 2024-03-15 |
| 2023-09-30 | $10.38K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $9.84K 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $2.93K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.91K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $43.10K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $43.05K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $42.95K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.86K 10-K · filed 2023-03-31 | $42.87K 10-K · filed 2022-03-29 |
| 2021-09-30 | $42.63K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $40.08K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $40.02K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $30.64K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $29.85K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $28.59K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $25.78K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $21.75K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $20.46K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $18.74K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $18.19K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $17.68K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $17.68K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $8.75K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $8.74K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $8.73K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $5.92K 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $5.68K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $5.47K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $5.47K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $3.75K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $32.86K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $31.37K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $3.13K 10-K · filed 2017-03-27 | $31.27K 10-K · filed 2016-03-24 |
| 2015-09-30 | $27.07K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $26.38K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $25.34K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $23.94K 10-K · filed 2016-03-24 | |
| 2014-09-30 | $22.05K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $20.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $19.85K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $19.63K 10-K · filed 2015-03-25 | |
| 2013-09-30 | $19.15K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $19.03K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $11.20K 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $11.17K 10-K · filed 2014-03-26 | |
| 2012-09-30 | $11.16K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $11.13K 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $11.12K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $11.11K 10-K · filed 2013-02-26 | |
| 2011-09-30 | $220.99K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $218.24K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $10.81K 10-K · filed 2012-03-27 | $216.19K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |